Insider Shareholders with Direct Ownership of Viking Therapeutics, Inc. (VKTX)
This section provides a comprehensive overview of the insiders with direct ownership of Viking Therapeutics, Inc. (VKTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Viking Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Brian Lian
President & CEO |
3,050,934 | 2,516,209 | 2,304,927 $97.6 Million | 48 |
Sep 20, 2024
Reduced 0.01%
|
|
Marianna Mancini
Chief Operating Officer |
1,040,371 | 784,215 | 362,149 $15.3 Million | 35 |
Jul 30, 2024
Reduced 0.91%
|
|
Greg Zante
Chief Financial Officer |
847,269 | 733,892 | 149,366 $6.33 Million | 36 |
Oct 28, 2024
Reduced 0.8%
|
|
Michael Morneau
VP, Finance and Administration |
21,334 | 4,424 | 116,062 $4.92 Million | 3 |
Jan 19, 2021
Reduced 1.43%
|
|
Matthew W Foehr
Director |
85,000 | 0 | 111,250 $4.71 Million | 3 |
May 02, 2022
Added 28.8%
|
| 54,786 | 54,786 | 47,965 $2.03 Million | 8 |
Nov 08, 2024
Reduced 4.0%
|
|
|
Charles A Rowland Jr
Director |
40,000 | 40,000 | 30,000 $1.27 Million | 2 |
May 16, 2023
Reduced 57.14%
|
| 68,786 | 68,786 | 9,500 $402,325 | 10 |
Oct 25, 2024
Reduced 62.75%
|
|
| 66,000 | 66,000 | 0 $0 | 6 |
Oct 25, 2024
Reduced 100.0%
|